Comment diagnostiquer une infection virale ?

Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques.

Quels tests sont utilisés pour les vaccins antiviraux ?

Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité.

Les symptômes indiquent-ils un besoin de vaccin ?

Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin.

Comment évaluer l'efficacité d'un vaccin ?

L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée.

Les tests de dépistage sont-ils nécessaires avant vaccination ?

Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination.

Quels symptômes nécessitent un vaccin antiviral ?

Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin.

Les effets secondaires des vaccins sont-ils fréquents ?

Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers.

Comment distinguer une infection d'un effet secondaire ?

Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires.

Les symptômes varient-ils selon le type de vaccin ?

Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle.

Les symptômes d'une infection virale sont-ils similaires ?

Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue.

Comment les vaccins antiviraux préviennent-ils les infections ?

Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques.

À quel âge doit-on commencer la vaccination antivirale ?

L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance.

Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?

Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin.

Les vaccins protègent-ils contre toutes les souches virales ?

Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires.

Quelle est l'importance de la vaccination de masse ?

La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus.

Les vaccins antiviraux sont-ils des traitements ?

Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes.

Quels traitements sont disponibles après infection ?

Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales.

Les vaccins peuvent-ils réduire la gravité des symptômes ?

Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination.

Les traitements sont-ils nécessaires après vaccination ?

Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination.

Les vaccins antiviraux nécessitent-ils des traitements préventifs ?

Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition.

Quelles complications peuvent survenir après vaccination ?

Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques.

Les complications sont-elles fréquentes ?

Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques.

Comment gérer les complications post-vaccinales ?

Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles.

Les complications varient-elles selon le vaccin ?

Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition.

Les complications peuvent-elles affecter l'immunité ?

Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare.

Quels sont les facteurs de risque pour les infections virales ?

Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression.

Les antécédents médicaux influencent-ils la vaccination ?

Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin.

Les voyages augmentent-ils le risque d'infection ?

Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques.

Les personnes âgées ont-elles plus de risques ?

Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections.

Le mode de vie influence-t-il le risque d'infection ?

Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque.

Vaccins antiviraux - Informations médicales vérifiées

Effect of Instrumented Spine Surgery on Length of Stay.

01 05 2023

DOI: 10.5435/JAAOSGlobal-D-22-00231 PMID: 37186578

Total joint arthroplasty studies have identified that surgeries that take place later in the week have a longer length of stay compared with those earlier in the week. This has not been demonstrated i... All instrumented spine surgeries in 2019 at a single academic tertiary center were retrospectively reviewed. Patients were categorized for surgical day and discharge disposition to home or a rehabilit... Seven hundred six patients were included in the analysis. Excluding Saturday, there were no differences in length of stay based on the day of surgery. Age older than 75 years, female, American Society... Day of surgery does not affect length of stay in instrumented spine surgeries. Discharge to a rehabilitation facility, however, did increase the length of stay as did age older than 75 years, higher A...

Humans Female United States Aged Length of Stay +4 autres

Perioperative risk factors impact on intensive care unit length of stay (ICU length of stay) in oral squamous cell carcinoma.

01 09 2023

DOI: 10.1186/s12903-023-03304-4 PMID: 37658335

The trend in postoperative care for free flap patients is to deescalate from routine ICU admission into a specialty recovery unit. This study aims to investigate the predictive parameters in a routine... All patients who underwent ablative surgery for OSCC with free flap reconstruction and were managed in the ICU were included in this study. The primary outcome was ICU-length of stay. Perioperative, o... The study included 136 homogeneous patients, with a mean ICU length of stay of 4.5 (± 4.43 day). Patients with pre-operative positive renal dysfunction (P = 0.004), peripheral vascular disease (P < 0.... Patients with perioperative severe renal dysfunction, peripheral vascular disease, postoperative complication or high NYHA class are prone to have a significantly longer ICU length of stay. Several fa...

Humans Carcinoma, Squamous Cell Squamous Cell Carcinoma of Head and Neck Length of Stay Mouth Neoplasms +6 autres

Frailty, length of stay and cost in hip fracture patients.

Jan 2023

DOI: 10.1007/s00198-022-06553-1 PMID: 36197493

A hip fracture causes high morbidity and mortality. Frailty is associated with adverse outcomes and increased costs. Frailty measured using the Hospital Frailty Risk Score (HFRS) is associated with hi... Hip fractures account for an increasing number of hospital admissions around the world and are associated with high rates of morbidity and mortality. Frailty is increasingly recognized to be associate... A retrospective analysis was performed on 1014 patients ≥ 60 years who presented with a hip fracture between January 2016 to June 2020. Each patient was classified into HFRS low, intermediate or high ... Median total hospitalization costs were significantly higher in the highest HFRS (SGD$22,432) patients as compared to intermediate (SGD$18,759) and low HFRS (SGD$15,671) patients. The difference betwe... Frailty is associated with a marked increase in total costs in hip fracture patients. HFRS proved useful in estimating LOS and outcomes for older patients with hip fractures....

Humans Aged Length of Stay Retrospective Studies Frailty +3 autres

Length of Stay in Patients Undergoing Tracheoplasty: A NSQIP Study.

08 2023

DOI: 10.1002/lary.30424 PMID: 36214517

Prolonged length of stay (LOS) has been associated with increased morbidity and resource utilization in various surgical procedures. We aim to determine factors associated with increased hospital stay... The 2012-2018 National Surgical Quality Improvement Program (NSQIP) database was queried for patients undergoing tracheoplasty. Patient LOS was the primary clinical outcome. A LOS >75th percentile was... A total of 252 patients were queried. The majority of patients were female (67.5%), white (82.4%), and over the age of 65 (77.0%). Patients had a median LOS of 7 days with the 75th percentile cutoff b... This study elucidates factors associated with prolonged LOS in patients undergoing tracheoplasty. Patients with COPD and chronic steroid use were significantly associated with prolonged LOS.... 4 Laryngoscope, 133:1938-1942, 2023....

Humans Male Female Quality Improvement Length of Stay +5 autres

Genetic Testing and Hospital Length of Stay in Neonates With Epilepsy.

08 2022

DOI: 10.1016/j.pediatrneurol.2022.05.011 PMID: 35751960

We evaluated changes in genetic testing for neonatal-onset epilepsy and associated short-term outcomes over an 8-year period among a cohort of patients in the neonatal intensive care unit (NICU) at a ... Our primary outcome was a change in length of stay (LOS) after 2018. We also ascertained severity of illness with the Neonatal Sequential Organ Failure Assessment (nSOFA), type and result of genetic t... Fifty-three infants with genetic testing were included; 20 infants were tested after 2018. A total of 4160 infants in the NICU without genetic testing were used as reference. In the genetic testing gr... In this cohort, changes in genetic testing for neonatal-onset epilepsy were associated with shorter LOS that was not explained by changes in severity of illness, birth weight, or the average LOS in th...

Birth Weight Epilepsy Genetic Testing Hospitals Humans +5 autres

[Laboratories as predictors of length of hospital stay in patients with pneumonia].

02 Jan 2023

PMID: 36542655

There are several factors that influence the length of hospital stay (LoHS) in patients with community-acquired pneumonia (CAP). There is currently no study in the literature that correlates laborator... To find the association of laboratory parameters with the LoHS in patients with community-acquired pneumonia.... An observational, prospective, longitudinal, and controlled study was conducted in the emergency room of a secondary level hospital.... The mean time of LoHS in patients with CAP was 6.6 ± 3.0 days. The parameters of laboratory of monocytes, basophils and segmented neutrophils presented a correlation (Spearman rho) of 0.363, 0.364 and... LoHS in patients with CAP is related to the counting of monocytes, basophils, and neutrophils at the time of the hospital admittance and it was increased in patients with SAH and patients with COPD....

Humans Length of Stay Prospective Studies Laboratories Pneumonia +3 autres

Laparoscopy in high-risk emergency general surgery reduces intensive care stay, length of stay and mortality.

24 Jan 2023

DOI: 10.1007/s00423-022-02744-w PMID: 36692646

Emergency general surgery patients undergoing laparoscopic surgery are at reduced risk of mortality and may require reduced length of critical care stay. This study investigated the effect of laparosc... Data were retrieved for all patients entered into the NELA database between 2013 and 2018. Only high-risk surgical patients (P-POSSUM predicted mortality risk of ≥ 5%) were included. Patients undergoi... A total of 66,517 high-risk patients received emergency major abdominal surgery. A laparoscopic procedure was attempted in 6998 (10.5%); of these, the procedure was competed laparoscopically in 3492 (... The results of this study suggest that in patients at high risk of post-operative mortality, laparoscopic emergency bowel surgery leads to a reduced length of critical care stay, overall length of sta...

Humans Length of Stay Laparoscopy Laparotomy Outcome Assessment, Health Care +4 autres

Factors associated with an extended length of stay in the pediatric burn patient.

03 2023

DOI: 10.1016/j.surg.2022.07.044 PMID: 37534708

The Center for Medicaid and Medicare Services predicts the length of stay for pediatric burn patients based on several variables. However, many patients exceed their anticipated length. This study loo... We conducted a retrospective chart review of 535 pediatric burn patients admitted to our academic hospital from January 2018 to December 2020. 405 patients met inclusion criteria. Data were collected ... Average patient age was 3.36 years. 72.3% were treated for scald burns. Average length of stay was 13.5 days. 20.5% (n = 83) of patients exceeded their predicted length of stay. In comparing patients ... Twenty percent of pediatric burn patients had a longer length of stay than predicted by the Center for Medicaid and Medicare Services. Many factors were strongly associated with a longer-than-predicte...

Aged Child Humans United States Child, Preschool +6 autres

Qualitative Analysis of Length of Stay and Readmission after Carotid Endarterectomy.

Mar 2023

DOI: 10.1016/j.avsg.2022.10.010 PMID: 36442710

Length of stay (LOS) and readmissions are common measures to evaluate quality of health care. The objective of this study was to evaluate factors related to hospital LOS and readmission within 90 days... Using a single institution database, patients who underwent CEA for carotid stenosis between 2014 and 2019 were identified. Asymptomatic carotid stenosis (no history of any stroke or transient ischemi... There were 125 patients identified who underwent CEA for 133 carotid stenosis, and 8 patients had bilateral CEA; of which 36.8% were asymptomatic carotid stenosis with the remaining being operated on ... More than half of patients undergoing CEA for carotid stenosis were discharged after postoperative day 1. Interventions on modifiable clinical risk factors, such as morning CEA scheduling and manageme...

Humans Female Aged Male Endarterectomy, Carotid +8 autres

Association of Prophylaxis and Length of Stay With Venous Thromboembolism in Abdominopelvic Surgery.

02 2023

DOI: 10.1016/j.jss.2022.10.001 PMID: 36327702

Extended venous thromboembolism prophylaxis (eVTEp) is recommended for select patients who have undergone major abdominopelvic surgery to prevent postdischarge venous thromboembolism (pdVTE). Criteria... A retrospective cohort study of patients undergoing abdominopelvic surgery from January 2016 to February 2020 was performed using data from the Michigan Surgical Quality Collaborative. pdVTE was the m... A total of 45,637 patients underwent abdominopelvic surgery. Of which, 3063 (6.71%) were prescribed eVTEp. Two hundred eighty-five (0.62%) had pdVTE. Of the 285, 59 (21%) patients received eVTEp, whil... pdVTE was associated with increasing LOS but not with other VTE risk factors after propensity score matching. Current guidelines for eVTEp do not include LOS. Our findings suggest that LOS >5 d should...

Humans Venous Thromboembolism Retrospective Studies Length of Stay Aftercare +4 autres

Vaccins antiviraux : Questions médicales fréquentes

Termes MeSH sélectionnés :

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Sous-catégories

Vaccins anti-adénovirus

Vaccins contre le SIDA

Vaccins contre la COVID-19

Vaccins contre le cytomégalovirus

Vaccins contre la dengue

Vaccins contre la maladie à virus Ebola

Vaccins contre les herpèsvirus

Vaccins antigrippaux

Vaccins contre l'encéphalite japonaise

Vaccin contre la rougeole

Vaccin antiourlien

Vaccins contre les papillomavirus

Vaccins contre les virus para-influenza

Vaccins antipoliomyélitiques

Vaccins contre la maladie d'Aujeszky

Vaccins antirabiques

Vaccins contre les virus respiratoires syncytiaux

Vaccins anti-rotavirus

Vaccin antirubéoleux

Vaccins contre le SIDA simien

Vaccin antivariolique

Vaccins contre les hépatites virales

Vaccins contre le virus du Nil occidental

Vaccin antiamaril

Vaccin ChAdOx1 nCoV-19

Ad26COVS1

Vaccin contre la varicelle

Vaccins contre les virus herpès simplex

Vaccins contre la maladie de Marek

Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18

Vaccin antipoliomyélitique inactivé

Vaccin antipoliomyélitique oral

Vaccin contre la rougeole, les oreillons et la rubéole

Vaccins anti-hépatite A

Vaccins anti-hépatite B

Vaccin contre le zona

Auteurs principaux

Sources (8671 au total)